ArticlePolymers2023
Development of Inkjet Printable Formulations Based on Polyorganosilazane and Divinylbenzene.
Article in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Within this work, ink formulations based on polyorganosilazane (OPSZ) and divinylbenzene (DVB) were developed to be processed by inkjet printing. The formulations were studied regarding their rheological, structural, and thermal properties. The rheological results show that the new formulations meet the requirements of the inkjet printer by showing both low viscosity (below 20 mPa∙s at printing temperature) and Newtonian flow behavior even at high shear rates. Additionally, the inks have surface tensions in the range of 21 to 26 mN/m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.